| Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators LV Rhodes, CR Tate, HC Segar, HE Burks, TB Phamduy, V Hoang, ... Breast cancer research and treatment 145, 593-604, 2014 | 97 | 2014 |
| Endocrine disruptors and the tumor microenvironment: a new paradigm in breast cancer biology H Burks, N Pashos, E Martin, J Mclachlan, B Bunnell, M Burow Molecular and cellular endocrinology 457, 13-19, 2017 | 53 | 2017 |
| Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived … RA Sabol, AC Bowles, A Côté, R Wise, B O’Donnell, MD Matossian, ... Breast Cancer Research 21, 1-14, 2019 | 52 | 2019 |
| Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1 LV Rhodes, CR Tate, VT Hoang, HE Burks, D Gilliam, EC Martin, S Elliott, ... Oncogenesis 4 (10), e168-e168, 2015 | 48 | 2015 |
| Laser direct‐write onto live tissues: a novel model for studying cancer cell migration HE Burks, TB Phamduy, MS Azimi, J Saksena, ME Burow, ... Journal of cellular physiology 231 (11), 2333-2338, 2016 | 37 | 2016 |
| Keratinocyte cadherin desmoglein 1 controls melanocyte behavior through paracrine signaling CR Arnette, QR Roth‐Carter, JL Koetsier, JA Broussard, HE Burks, ... Pigment cell & melanoma research 33 (2), 305-317, 2020 | 36 | 2020 |
| Translational implications of Th17-skewed inflammation due to genetic deficiency of a cadherin stress sensor LM Godsel, QR Roth-Carter, JL Koetsier, LC Tsoi, AL Huffine, ... The Journal of Clinical Investigation 132 (3), 2022 | 33 | 2022 |
| miR-155 induced transcriptome changes in the MCF-7 breast cancer cell line leads to enhanced mitogen activated protein kinase signaling EC Martin, AE Krebs, HE Burks, S Elliott, M Baddoo, BM Collins-Burow, ... Genes & cancer 5 (9-10), 353, 2014 | 27 | 2014 |
| Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model MD Matossian, HE Burks, S Elliott, VT Hoang, AC Bowles, RA Sabol, ... BMC cancer 19, 1-17, 2019 | 26 | 2019 |
| A novel patient-derived xenograft model for claudin-low triple-negative breast cancer MD Matossian, HE Burks, AC Bowles, S Elliott, VT Hoang, RA Sabol, ... Breast cancer research and treatment 169, 381-390, 2018 | 25 | 2018 |
| A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma S Piperno-Neumann, MS Carlino, V Boni, D Loirat, FM Speetjens, JJ Park, ... British journal of cancer 128 (6), 1040-1051, 2023 | 24 | 2023 |
| Glyceollin I reverses epithelial to mesenchymal transition in letrozole resistant breast cancer through ZEB1 PP Carriere, SD Llopis, AC Naiki, G Nguyen, T Phan, MM Nguyen, ... International journal of environmental research and public health 13 (1), 10, 2016 | 24 | 2016 |
| Desmoglein 1 regulates invadopodia by suppressing EGFR/Erk signaling in an Erbin-dependent manner A Valenzuela-Iglesias, HE Burks, CR Arnette, A Yalamanchili, ... Molecular Cancer Research 17 (5), 1195-1206, 2019 | 21 | 2019 |
| Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model MD Matossian, HE Burks, S Elliott, VT Hoang, AC Bowles, RA Sabol, ... Oncoscience 5 (3-4), 99, 2018 | 21 | 2018 |
| In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within … MD Matossian, T Chang, MK Wright, HE Burks, S Elliott, RA Sabol, ... Clinical and Translational Oncology 24 (1), 127-144, 2022 | 18 | 2022 |
| Aging is associated with impaired angiogenesis, but normal microvascular network structure, in the rat mesentery RS Sweat, DC Sloas, SA Stewart, M Czarny-Ratajczak, M Baddoo, ... American Journal of Physiology-Heart and Circulatory Physiology 312 (2 …, 2017 | 18 | 2017 |
| Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor TC Chang, MD Matossian, S Elliott, HE Burks, RA Sabol, DA Ucar, ... PLoS One 15 (10), e0226464, 2020 | 17 | 2020 |
| ERK5 is required for tumor growth and maintenance through regulation of the extracellular matrix in triple negative breast cancer VT Hoang, MD Matossian, DA Ucar, S Elliott, J La, MK Wright, HE Burks, ... Frontiers in Oncology 10, 1164, 2020 | 17 | 2020 |
| Argonaute 2 expression correlates with a luminal B breast cancer subtype and induces estrogen receptor alpha isoform variation AK Conger, EC Martin, TJ Yan, LV Rhodes, VT Hoang, J La, M Anbalagan, ... Non-coding RNA 2 (3), 8, 2016 | 17 | 2016 |
| Dual Src kinase/pretubulin inhibitor KX-01, sensitizes ERα-negative breast cancers to tamoxifen through ERα reexpression M Anbalagan, M Sheng, B Fleischer, Y Zhang, Y Gao, V Hoang, ... Molecular Cancer Research 15 (11), 1491-1502, 2017 | 16 | 2017 |
